Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Authors: Peter J Goadsby, David W Dodick, Jessica Ailani, Joel M Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3050017463
